Global Anti-tuberculosis Therapeutics Market Share

Statistics for the 2023 & 2024 Global Anti-tuberculosis Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Global Anti-tuberculosis Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Anti-tuberculosis Therapeutics Industry

The anti-tuberculosis therapeutics market is highly consolidated, with very few companies holding a substantial market share. With the rising focus of the healthcare sector on the development of novel drugs and the growing investment in research and development, more small to mid-sized companies are estimated to enter the market in the coming future. Some of the companies in the market are Lupin, Macleods Pharmaceuticals Ltd, Otsuka Pharmaceutical Co. Ltd, and Johnson and Johnson holds the largest market share.

Anti-tuberculosis Therapeutics Market Leaders

  1. Macleods Pharmaceuticals Ltd

  2. Otsuka Pharmaceutical Co. Ltd

  3. Johnson and Johnson

  4. Sequella, Inc.

  5. Lupin Limited

*Disclaimer: Major Players sorted in no particular order

Anti-Tuberculosis Drugs Market Concentration

Anti-tuberculosis Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)